This is a type of cancer that starts in the lymphatic system, which is part of your immune system. It causes swollen lymph nodes, often in the neck or armpits. It's called Hodgkin's Lymphoma.
Every report comes from a Lived member, sent anonymously.
Have you tried Adcetris (Brentuximab Vedotin) for Hodgkin Lymphoma?
Hodgkin lymphoma, once called Hodgkin disease, is a cancer of the lymph system: the network of lymph nodes, lymph vessels, spleen, bone marrow and related tissue that forms part of the immune system. It begins in a type of white blood cell called a lymphocyte. The most common first sign is a painless swollen lymph node, usually in the neck, armpit or groin, though it often involves nodes in the middle of the chest that can only be seen on a scan. Some people also have fevers without an infection, drenching night sweats, weight loss they can't explain, ongoing tiredness or itchy skin. Hodgkin lymphoma is one of the two main groups of lymphoma. The other, non-Hodgkin lymphoma, includes many different diseases that behave and are treated differently. Most Hodgkin lymphoma is the classic type, recognized under the microscope by large abnormal cells called Reed-Sternberg cells. A rarer form, nodular lymphocyte-predominant Hodgkin lymphoma, tends to grow more slowly and is often managed differently. Hodgkin lymphoma is one of the more treatable cancers: it can usually be cured when found and treated early, and many people whose disease has already spread also do well.
The cause of Hodgkin lymphoma is unknown, and many people who develop it have few or no known risk factors. Because so few of those factors can be changed, most cases can't be prevented. It is most often diagnosed in young adults, especially in their 20s, and again in later life. It is slightly more common in males. Past infection with the Epstein-Barr virus (EBV), the virus that causes mononucleosis (mono), raises the risk, but most people have had EBV and very few of them ever develop Hodgkin lymphoma. Having a parent, brother or sister with the disease raises risk somewhat, although most people with Hodgkin lymphoma have no family history of it. A weakened immune system also increases risk, including from HIV (the virus that causes AIDS), from medicines that suppress immunity after an organ transplant, and with some autoimmune diseases.
Most swollen lymph nodes are caused by infections. Those nodes are often tender and shrink once the infection clears. A node that keeps growing, stays enlarged without a recent infection, or comes with fevers, night sweats or weight loss needs a closer look. The diagnosis can only be confirmed by a biopsy: removing a whole lymph node, part of one, or a core of tissue with a wide needle, so a pathologist can examine it under the microscope and with lab tests that identify the type of lymphoma. Once Hodgkin lymphoma is confirmed, staging shows how far it has spread. The main test is usually a PET-CT scan, which combines detailed computed tomography (CT) images with a positron emission tomography (PET) scan showing where cells are using unusually large amounts of sugar, as lymphoma cells do. Stages I and II mean the lymphoma is on only one side of the diaphragm, the breathing muscle beneath the lungs. Stage III means lymph nodes both above and below the diaphragm are involved. Stage IV means it has spread into an organ such as the liver, lungs or bone marrow. Doctors also record B symptoms: fever without an infection, drenching night sweats, and losing more than 10 percent of body weight over six months without trying. B symptoms, a very large mass in the chest, lymphoma in several node areas, and a high erythrocyte sedimentation rate (ESR, a blood test of inflammation) can place early-stage disease in an unfavorable group that usually gets more treatment. Other blood tests check blood counts and organ function and look for HIV and hepatitis B and C, which affect treatment planning.
Treatment is planned by a team experienced with lymphoma, usually led by a medical oncologist or hematologist (a blood cancer specialist). The plan depends on the type and stage, whether the disease is in the favorable or unfavorable group, age and overall health. For most people, the goal is cure. For classic Hodgkin lymphoma, the core of treatment is combination chemotherapy, given in cycles of a few weeks each, usually at an outpatient clinic. A long-standing regimen is ABVD, named for its four drugs: doxorubicin, bleomycin, vinblastine and dacarbazine. In early-stage disease, a few cycles may be followed by radiation aimed only at the areas the lymphoma involved, or chemotherapy may be given alone. A PET-CT scan partway through treatment shows how well the lymphoma is responding and helps decide how much more treatment is needed, which can spare some people radiation or extra cycles. Stage III and IV disease is treated with more intensive chemotherapy, often combined with a newer drug. Nivolumab (Opdivo) is an immunotherapy that releases a brake on the immune system's T cells so they can attack lymphoma cells; it is approved with AVD, the ABVD drugs minus bleomycin. Brentuximab vedotin (Adcetris) is an antibody that carries a chemotherapy drug directly to lymphoma cells; it is also approved with AVD and is part of other regimens. Which combination fits depends on age, health and how each option's side effects weigh up for that person. If lymphoma doesn't respond or comes back, options include different chemotherapy, immunotherapy with nivolumab or pembrolizumab (Keytruda), brentuximab vedotin, and high-dose chemotherapy followed by a stem cell transplant, in which blood-forming cells collected earlier are returned to rebuild the bone marrow. Some people are still cured at this stage. Nodular lymphocyte-predominant Hodgkin lymphoma follows a different path: early disease may be closely watched or treated with radiation alone, and the antibody rituximab may be used. The trade-offs reach beyond the treatment months. Chemotherapy commonly causes fatigue, nausea, hair loss, mouth sores and a higher chance of infection while blood counts are low. Doxorubicin can damage the heart and bleomycin the lungs, so heart and lung function may be tested before and during treatment. Chemotherapy and radiation can reduce fertility, so anyone who may want children should ask about fertility preservation, such as sperm banking, before treatment begins. When Hodgkin lymphoma is found during pregnancy, the plan is built around the stage and the pregnancy, and when it is diagnosed in the second half of pregnancy, treatment can often wait until after delivery.
Initial treatment usually spans several months of repeated chemotherapy cycles, with blood tests before each one and scans to check the response. Many people keep up some work, study or family routines, planning around the days when fatigue and nausea are worst; others need to step back more. Infection risk is highest at the point in each cycle when white blood cells are lowest, so hand washing, avoiding people who are sick and careful food handling become part of daily life during treatment. The outlook is good for most people. In the United States, the five-year relative survival for Hodgkin lymphoma is about 89 percent, and about 84 percent when it has already spread to distant parts of the body at diagnosis. Relative survival compares people with the cancer to people without it, so 89 percent means people with Hodgkin lymphoma are, on average, about 89 percent as likely to be alive five years later. These figures come from people diagnosed between 2015 and 2021, many of whom were cured, and they cannot predict any one person's course. After treatment, follow-up visits are usually every 3 to 6 months for the first several years, then less often, and many people still see their oncologist once a year after five years. These visits watch for the lymphoma coming back, which can sometimes happen many years later, and for late effects of treatment. Late effects can appear a decade or more on and include second cancers (such as breast cancer after chest radiation, particularly before age 30, as well as leukemia, lung and thyroid cancers), heart disease, an underactive thyroid after neck or chest radiation, lung problems, infertility and lasting fatigue. Modern treatment uses lower radiation doses aimed at smaller areas, which likely lowers these risks. A written survivorship care plan, copies of treatment records, not smoking and the extra screening a team recommends, such as earlier breast screening with MRI for women who had chest radiation when young, help keep long-term health on track. Worry and low mood are common during and after treatment, and support groups and counseling can help.
See a doctor about a swollen lymph node that doesn't go away, especially if you haven't had a recent infection, or about unexplained fevers, drenching night sweats, weight loss without trying, or itching or tiredness that persists. Contact a doctor soon about a new cough, pain behind the breastbone, or trouble breathing that is worse when lying flat, since enlarged lymph nodes in the chest can press on the windpipe. During chemotherapy, call your cancer care team right away for a temperature of 100.5°F (38°C) or higher, or for chills or other signs of infection. Infections during treatment, when white blood cells are low, can become life threatening and need urgent care. Ask the team before taking acetaminophen or ibuprofen for a fever, because these can hide the signs they need to see. After treatment ends, tell the team about any new or returning symptom rather than waiting for the next scheduled visit.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share what living with Hodgkin Lymphoma is like, what's helped you, or ask the community a question.